# Exploratory Clinical Trials of ACM-1 in the Treatment of Ophthalmological Neovascular Diseases

> **NCT02448732** · EARLY_PHASE1 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 10 (estimated)

## Conditions studied

- Neovascularization, Pathologic

## Interventions

- **DRUG:** ACM-1

## Key facts

- **NCT ID:** NCT02448732
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-12
- **Primary completion:** 2016-04
- **Final completion:** 2016-06
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2015-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02448732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02448732, "Exploratory Clinical Trials of ACM-1 in the Treatment of Ophthalmological Neovascular Diseases". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02448732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*